BHG

BHG, founded in 2006 and headquartered in Texas, is the largest network of Joint Commission-accredited outpatient opioid treatment and recovery centers in the U.S. The company specializes in delivering comprehensive, personalized, evidence-based medical and behavioral therapies for individuals suffering from opioid use disorder (OUD). With a significant operational footprint, BHG manages 84 locations nationwide, serving a critical need in the healthcare sector. Its core offerings revolve around medication-assisted treatment (MAT) and a full spectrum of recovery services designed to support patients through their journey to sobriety.

Operating within the healthcare industry, BHG employs between 1,000 and 5,000 individuals across its extensive network. The company's commitment to quality is underscored by its Joint Commission accreditation, signifying adherence to high standards in patient care and operational excellence. BHG's approach integrates both medical interventions and behavioral therapies, aiming for superior patient outcomes. For insights into the dedicated professionals driving these efforts, consider Meet BHG's team. The company's revenue reached $439.8M, reflecting its substantial market presence and the demand for its specialized services.

BHG competes in a dynamic market against entities like American Addiction Centers and Summit BHC, positioning itself as a leader in OUD treatment. Its product portfolio includes various treatment programs, recovery services, and medication-assisted treatment options, all tailored to individual patient needs. The company's strategic focus on evidence-based practices and a patient-centric model solidifies its role as a key provider in behavioral health. BHG's extensive network and specialized services address a critical public health challenge, offering hope and recovery pathways for thousands.